Page 1,073«..1020..1,0721,0731,0741,075..1,0801,090..»

Theter systems market is predicted to grow to $656.8 million by 2024, witnessing a significant jump in its revenue from $493.5 million in 2018 – Yahoo…

Posted: Published on January 31st, 2020

Robotic Catheter Systems Market Research Report: By Type (Multi-Specialty Systems, Single-Specialty Systems), Technology (Electromechanical, Magnetic), Application (Interventional Electrophysiology Procedures, Peripheral Vascular Procedures), Component (Systems, Accessories), End User (Hospitals, ASCs), Geographical Outlook (U. New York, Jan. Continue reading →

Posted in Interventional Cardiology | Comments Off on Theter systems market is predicted to grow to $656.8 million by 2024, witnessing a significant jump in its revenue from $493.5 million in 2018 – Yahoo…

Global Interventional Cardiology Market to Grow at a CAGR of 6.9% with estimated revenue of USD 21.88 billion by 2022 – Briotainment

Posted: Published on January 31st, 2020

Global Interventional Cardiology market from the in depth perspective of all the ongoing trends that are affecting the market and are important to be understood are studied. These trends are geographical, economic, socioeconomic, political, cultural, political, and many other are studied Continue reading →

Posted in Interventional Cardiology | Comments Off on Global Interventional Cardiology Market to Grow at a CAGR of 6.9% with estimated revenue of USD 21.88 billion by 2022 – Briotainment

Work in Healthcare? ZDoggMD Wants Your Voice to Be Heard – Medscape

Posted: Published on January 31st, 2020

This transcript has been edited for clarity. Eric J. Continue reading →

Posted in Interventional Cardiology | Comments Off on Work in Healthcare? ZDoggMD Wants Your Voice to Be Heard – Medscape

Boston Scientific Co. (NYSE:BSX) Shares Sold by Conning Inc. – Riverton Roll

Posted: Published on January 31st, 2020

Conning Inc. Continue reading →

Posted in Interventional Cardiology | Comments Off on Boston Scientific Co. (NYSE:BSX) Shares Sold by Conning Inc. – Riverton Roll

ABIOMED (ABMD) Scheduled to Post Earnings on Thursday – Tech Know Bits

Posted: Published on January 31st, 2020

ABIOMED (NASDAQ:ABMD) is scheduled to be posting its quarterly earnings results before the market opens on Thursday, February 6th. Analysts expect ABIOMED to post earnings of $1.09 per share for the quarter Continue reading →

Posted in Interventional Cardiology | Comments Off on ABIOMED (ABMD) Scheduled to Post Earnings on Thursday – Tech Know Bits

Doctors Hoping Pill Form Of ALS Drug Will Be Less Intense Treatment For Patients – CBS Pittsburgh

Posted: Published on January 31st, 2020

PITTSBURGH (KDKA) Doctors are trying to make an FDA-approved drug treatment for Amyotrophic Lateral Sclerosis, or ALS, much less intense for both patients and caregivers. Continue reading →

Posted in ALS Treatment | Comments Off on Doctors Hoping Pill Form Of ALS Drug Will Be Less Intense Treatment For Patients – CBS Pittsburgh

BrainStorm Receives Notice of Intention to Grant Additional EU patent for NurOwn – Yahoo Finance

Posted: Published on January 31st, 2020

NEW YORK, Jan. 29, 2020 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc.(NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that the European Patent Office (EPO) has communicated its intention to grant a European patent titled 'Methods of Generating Mesenchymal Stem Cells which secrete Neurotrophic Factors'. Allowed claims cover the method for manufacturing MSC-NTF cells (NurOwn) Continue reading →

Posted in ALS Treatment | Comments Off on BrainStorm Receives Notice of Intention to Grant Additional EU patent for NurOwn – Yahoo Finance

GeNeuro: Cash position at December 31, 2019, Business Update and Outlook for 2020 – Business Wire

Posted: Published on January 31st, 2020

GENEVA--(BUSINESS WIRE)--Regulatory News: GeNeuro (Paris:GNRO) (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing new treatments focused on stopping causal factors driving the progression of neurodegenerative and autoimmune diseases, today announced its cash position at December 31, 2019, issued a business update and provided an outlook on its 2020 activities. GeNeuro continued to make significant clinical progress in 2019, said Jess Martin-Garcia, CEO of GeNeuro. The full 2-year results of our ANGEL-MS clinical trial of temelimab in multiple sclerosis, which were presented in September at the ECTRIMS 2019 congress, have confirmed the neuroprotective effect of temelimab in MS and demonstrated its potential against progression of the disease Continue reading →

Posted in ALS Treatment | Comments Off on GeNeuro: Cash position at December 31, 2019, Business Update and Outlook for 2020 – Business Wire

Invicro Scientists Work on Imaging Synaptic Density in Schizophrenia Published in Nature Communications – Yahoo Finance

Posted: Published on January 31st, 2020

Invicro LLC, a Konica Minolta company announces that the paper "Synaptic Density Marker SV2A is Reduced in Schizophrenia Patients and Unaffected by Antipsychotics in Rats1" has been published in Nature Communications. Invicro is a global provider of imaging biomarkers, core lab services, advanced analytics and software solutions for drug discovery and development. Continue reading →

Posted in Molecular Cardiology | Comments Off on Invicro Scientists Work on Imaging Synaptic Density in Schizophrenia Published in Nature Communications – Yahoo Finance

Medical Imaging Equipment Market Size 2020, Trends, Industry Share, Business Opportunities and Demand Forecast to 2025 – Medical Market News

Posted: Published on January 31st, 2020

Increasing cases of diseases such as cancer, and orthopedic disorders are likely to propel growth of the medical imaging equipment market says Fortune Business Insights in a published report, titled Medical Imaging Equipment Market Size, Share and Global Trend by Type (Magnetic Resonance Imaging Equipment, Computed Tomography Equipment, X-ray Equipment, Ultrasound Equipment Molecular Imaging Equipment), By Application (Cardiology, Neurology, Orthopedics, Gynecology, Oncology), By End-User (Hospitals, Specialty Clinics, Diagnostic Imaging Centers, Others) and Geography Forecast till 2026.As per the report, the market is projected to reach a value of US$ 44,077.7 Mn at a CAGR of 4.6% by 2025 from US$ 30,814.2 Mn in 2017. The report covers: Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/medical-imaging-equipment-market-100382 Leading Players operating in the Medical Imaging Equipment Market are: Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Continue reading →

Posted in Molecular Cardiology | Comments Off on Medical Imaging Equipment Market Size 2020, Trends, Industry Share, Business Opportunities and Demand Forecast to 2025 – Medical Market News

Page 1,073«..1020..1,0721,0731,0741,075..1,0801,090..»